Temi Adedoyin

1.5k total citations
3 papers, 18 citations indexed

About

Temi Adedoyin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Temi Adedoyin has authored 3 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Temi Adedoyin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). Temi Adedoyin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). Temi Adedoyin collaborates with scholars based in United Kingdom. Temi Adedoyin's co-authors include Kai‐Keen Shiu, Richard H. Wilson, Rubina Begum, Janet Graham, Mark Saunders, Andrew Plumb, Austin Obichere, Manuel Rodriguez‐Justo, Timothy Iveson and Khurum Khan and has published in prestigious journals such as Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Temi Adedoyin

2 papers receiving 18 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Temi Adedoyin United Kingdom	2	11	10	10	5	3	3	18
Matteo Papandrea Italy	2	5 0.5×	13 1.3×	17 1.7×	4 0.8×	4 1.3×	3	22
Eid Hanna Hungary	2	10 0.9×	5 0.5×	10 1.0×	5 1.0×	2 0.7×	6	25
Rita Canotilho Portugal	3	16 1.5×	14 1.4×	6 0.6×	7 1.4×	4 1.3×	10	25
Jenna Sinopoli United States	4	8 0.7×	7 0.7×	20 2.0×	5 1.0×	3 1.0×	4	23
Mollie L. Hutton United States	2	6 0.5×	11 1.1×	5 0.5×	7 1.4×	2 0.7×	2	25
Sara Corral Moreno Spain	3	8 0.7×	5 0.5×	8 0.8×	14 2.8×	3 1.0×	8	21
Maria Papadoliopoulou Greece	4	12 1.1×	8 0.8×	7 0.7×	3 0.6×	12 4.0×	7	36
Nadeera de Silva United Kingdom	2	7 0.6×	4 0.4×	7 0.7×	10 2.0×	4 1.3×	2	18
T AlSumai Saudi Arabia	3	5 0.5×	6 0.6×	10 1.0×	8 1.6×	8 2.7×	4	26
Gaëlle Sickersen France	2	4 0.4×	7 0.7×	17 1.7×	3 0.6×	3 1.0×	3	20

Countries citing papers authored by Temi Adedoyin

Since Specialization

Citations

This map shows the geographic impact of Temi Adedoyin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Temi Adedoyin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Temi Adedoyin more than expected).

Fields of papers citing papers by Temi Adedoyin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Temi Adedoyin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Temi Adedoyin. The network helps show where Temi Adedoyin may publish in the future.

Co-authorship network of co-authors of Temi Adedoyin

This figure shows the co-authorship network connecting the top 25 collaborators of Temi Adedoyin. A scholar is included among the top collaborators of Temi Adedoyin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Temi Adedoyin. Temi Adedoyin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Hawkins, M., Juan W. Valle, Harpreet Wasan, et al.. (2024). Addition of stereotactic body radiotherapy (SBRT) to systemic chemotherapy in locally advanced cholangiocarcinoma (CC) (ABC-07): Results from a randomized phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4006–4006. 5 indexed citations

2.

Brand, Douglas, Juan W. Valle, Harpreet Wasan, et al.. (2024). The Effect of Tumor Biological Effective Dose (BED) on Stereotactic Body Radiotherapy (SBRT) Outcomes for Locally Advanced Cholangiocarcinoma (CCA): An Analysis of the ABC-07 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S142–S143.

3.

Shiu, Kai‐Keen, Mark Saunders, Jenny F. Seligmann, et al.. (2024). NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA3504–LBA3504. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact